China Pharma Holdings, Inc.
CPHI
$1.50
-$0.0634-4.06%
AMEX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 4.53M | 5.54M | 6.25M | 6.42M | 7.01M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.53M | 5.54M | 6.25M | 6.42M | 7.01M |
| Cost of Revenue | 6.51M | 7.45M | 7.87M | 7.17M | 7.29M |
| Gross Profit | -1.99M | -1.90M | -1.62M | -749.10K | -281.20K |
| SG&A Expenses | 2.32M | 2.24M | 2.20M | 2.27M | 2.23M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.12M | 10.12M | 10.45M | 9.69M | 9.76M |
| Operating Income | -4.59M | -4.58M | -4.21M | -3.27M | -2.75M |
| Income Before Tax | -4.74M | -4.74M | -4.40M | -3.56M | -3.08M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.74 | -4.74 | -4.40 | -3.56 | -3.08 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.74M | -4.74M | -4.40M | -3.56M | -3.08M |
| EBIT | -4.59M | -4.58M | -4.21M | -3.27M | -2.75M |
| EBITDA | -1.97M | -1.71M | -1.35M | -462.90K | 1.80K |
| EPS Basic | -2.80 | -3.96 | -6.25 | -8.87 | -11.09 |
| Normalized Basic EPS | -1.75 | -2.47 | -3.91 | -5.54 | -6.93 |
| EPS Diluted | -2.80 | -3.96 | -6.25 | -8.87 | -11.09 |
| Normalized Diluted EPS | -1.75 | -2.47 | -3.91 | -5.54 | -6.93 |
| Average Basic Shares Outstanding | 6.96M | 5.38M | 3.92M | 2.47M | 1.32M |
| Average Diluted Shares Outstanding | 6.96M | 5.38M | 3.92M | 2.47M | 1.32M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |